Texas Heart Institute Cardiometabolic Syndrome Conference 2024

Texas Heart Institute Cardiometabolic Syndrome Conference 2024

Regular price€20,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

Texas Heart Institute Cardiometabolic Syndrome Conference 2024

Include: 20 videos, size: 4.67 GB
Target Audience: cardiologists, internists, hepatologists, endocrinologists, rheumatologists, pulmonologists, neurologists, gastroenterologists, surgeons
Information:


Cardiometabolic syndrome (CMS) is a complex medical condition associated with significant morbidity, mortality, and cost. It is increasingly appreciated that the condition is also linked to non-cardiac disease including fatty liver disease and cancer. The underlying pre-morbid conditions for CMS include hypertension, insulin resistance and type II diabetes, elevated serum lipids, and obesity.

Despite a deep understanding of the roles these pre-morbid conditions have on cardiovascular disease, liver disease, and malignancy and increasingly effective treatment strategies, the most recent projections from the US census and NHANES predict dramatic growth in each of the risk factors and subsequent clinical disease. This suggests that we need to look beyond standard healthcare solutions to the social drivers of health, new community partnerships, and innovative research programs if we intend to alter the trajectory of CMS. The proposed program will convene key stakeholders across a variety of disciplines to re-imagine new approaches for CMS.

The Cardiometabolic Syndrome Conference is designed to provide attendees with the most contemporary knowledge about the syndrome, including the epidemiology, treatment strategies, and knowledge gaps. There will be a specific focus on high-level discussions that dissect the current shortcomings in the overall management of CMS at the individual and community level and begin to consider new and innovative treatment strategies. The target audience is intended to be multidisciplinary and includes cardiologists, internal/general medicine practitioners, hepatologists, endocrinologists, rheumatologists, pulmonologists, neurologists, gastroenterologists, surgeons, residents and fellows, physician assistants, nurse practitioners, nurses, and other allied health professionals.

Texas Heart Institute Cardiometabolic Syndrome Conference 2024

Learning Objectives

At the conclusion of each lecture in the series, the participant should be able to:
• Define the current epidemiology of CMS and its clinical consequences.
• Review a guideline-based approach to screening and treatment of CMS.
• Assess the growing burden of CMS on children.
• Discuss prescribing food as a treatment for CMS.
• Consider how to meaningfully integrate the social drivers of health into clinical practice.


Texas Heart Institute Cardiometabolic Syndrome Conference 2024

 Topics:
  • An Employer Perspective on Community Health Initiatives.mp4
    Behavior Change and Health Outcomes in the Age of AI.mp4
    Cardiometabolic Syndrome in Children A Sign of Things To Come.mp4
    Cardiometabolic Syndrome in Women.mp4
    Changing Dietary Habits at the Population Level.mp4
    Defining the Epidemiologic Scope of Cardiometabolic Syndrome.mp4
    From Streets to Heartbeats Urban Environment and Cardiometabolic Health.mp4
    Impact of Contemporary Therapies on CMS.mp4
    Implementation Science to Improve Patient Engagement and Leveraging Systems to Enhance Care.mp4
    Leveraging Community Resources to Support Mental Health in the Workplace.mp4
    Looking at Community Health Trends with Survey Data The Greater Houston Community Panel.mp4
    National Priorities on Lifestyle and Cardiometabolic Health.mp4
    Opening Plenary Session Panel Discussion Q&A.mp4
    Research and Community Health Priorities Panel Discussion Q&A.mp4
    Technology & Digital Health Innovations Non-Medical Management Panel Discussion Q&A.mp4
    The Role of Local and State Governments.mp4
    Using Big Data to Understand and Treat Cardiometabolic Syndrome.mp4
    We Have the Tools, It’s Time To Unite The Intersection of CMH & MASLD MASH.mp4
    We Know What To Do. Why Isn’t It Working.mp4
    What the Guidelines Tell Us About Cardiometabolic Syndrome.mp4

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed